ArticleChemMedChem2016

Disarming an Electrophilic Warhead: Retaining Potency in Tyrosine Kinase Inhibitor (TKI)-Resistant CML Lines While Circumventing Pharmacokinetic Liabilities.

Ahmed M Ali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.